Healthcare company Abbott Laboratories (NYSE: ABT) announced financial results for the first quarter of 2023, reporting a decline in net sales and
Infographic: Highlights of Abbott Laboratories’ Q1 2023 results
Healthcare company Abbott Laboratories (NYSE: ABT) announced financial results for the first quarter of 2023, reporting a decline in net sales and adjusted earnings. First-quarter net sales dropped 18% year-over-year to $9.75 billion. The decline is primarily due to a
























